The University of Chicago Header Logo

Connection

Richard Quigg to Complement Activation

This is a "connection" page, showing publications Richard Quigg has written about Complement Activation.
Connection Strength

3.061
  1. Complement regulation in renal disease models. Semin Nephrol. 2013 Nov; 33(6):575-85.
    View in: PubMed
    Score: 0.445
  2. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis. Lab Invest. 2007 Apr; 87(4):357-64.
    View in: PubMed
    Score: 0.279
  3. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure. J Am Soc Nephrol. 2007 Mar; 18(3):811-22.
    View in: PubMed
    Score: 0.278
  4. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol. 2005 May; 16(5):1214-22.
    View in: PubMed
    Score: 0.245
  5. Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. J Am Soc Nephrol. 2003 Oct; 14(10):2516-25.
    View in: PubMed
    Score: 0.221
  6. Rat glomerular epithelial cells produce and bear factor H on their surface that is up-regulated under complement attack. Kidney Int. 2003 Sep; 64(3):914-22.
    View in: PubMed
    Score: 0.220
  7. Complement: Functions, location and implications. Immunology. 2023 10; 170(2):180-192.
    View in: PubMed
    Score: 0.216
  8. Glomerular complement regulation is overwhelmed in passive Heymann nephritis. Kidney Int. 2001 Sep; 60(3):900-9.
    View in: PubMed
    Score: 0.191
  9. Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure. Kidney Int. 2000 Oct; 58(4):1580-7.
    View in: PubMed
    Score: 0.180
  10. Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis. J Immunol. 1995 Apr 01; 154(7):3437-43.
    View in: PubMed
    Score: 0.123
  11. Abnormal immune complex processing and spontaneous glomerulonephritis in complement factor H-deficient mice with human complement receptor 1 on erythrocytes. J Immunol. 2010 Sep 15; 185(6):3759-67.
    View in: PubMed
    Score: 0.089
  12. The role of the complement cascade in endotoxin-induced septic encephalopathy. Lab Invest. 2007 Dec; 87(12):1186-94.
    View in: PubMed
    Score: 0.073
  13. Mouse podocyte complement factor H: the functional analog to human complement receptor 1. J Am Soc Nephrol. 2007 Apr; 18(4):1157-66.
    View in: PubMed
    Score: 0.070
  14. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J Immunol. 2005 Dec 15; 175(12):8312-9.
    View in: PubMed
    Score: 0.064
  15. Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics? Kidney Int. 2005 May; 67(5):1692-703.
    View in: PubMed
    Score: 0.062
  16. Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes. Kidney Int. 2002 Dec; 62(6):2010-21.
    View in: PubMed
    Score: 0.052
  17. Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure. J Am Soc Nephrol. 2001 Jan; 12(1):71-79.
    View in: PubMed
    Score: 0.046
  18. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med. 1998 Oct 05; 188(7):1321-31.
    View in: PubMed
    Score: 0.039
  19. Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity. Immunol Invest. 2017 Nov; 46(8):816-832.
    View in: PubMed
    Score: 0.037
  20. C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus. Immunology. 2015 Sep; 146(1):130-43.
    View in: PubMed
    Score: 0.031
  21. Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice. Immunology. 2013 Jul; 139(3):328-37.
    View in: PubMed
    Score: 0.027
  22. C5a alters blood-brain barrier integrity in experimental lupus. FASEB J. 2010 Jun; 24(6):1682-8.
    View in: PubMed
    Score: 0.021
  23. C3aR inhibition reduces neurodegeneration in experimental lupus. Lupus. 2010 Jan; 19(1):73-82.
    View in: PubMed
    Score: 0.021
  24. C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. J Immunol. 2007 Feb 01; 178(3):1819-28.
    View in: PubMed
    Score: 0.017
  25. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10837-42.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.